Treatment for gynecological cancers, including ovarian, cervical, and endometrial cancers, has seen significant advancements. Targeted therapies and immunotherapies are offering new hope. These treatments specifically target cancer cells while sparing healthy tissue, reducing side effects. Additionally, PARP inhibitors have emerged as effective treatments for ovarian cancer, particularly in patients with BRCA mutations.
